Canada Markets closed

EXMceuticals Inc. (9OM1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.12300.0000 (0.00%)
At close: 09:03AM CET

EXMceuticals Inc.

421 7th Avenue SW
30th Floor
Calgary, AB T2P 4K9
587 390 8541

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Jonathan William SummersExec. ChairmanN/AN/A1971
Ms. Julie LemieuxCEO, VP of Canadian Operations & Corp. Sec.N/AN/AN/A
Mr. Michael Winslow Kinley C.A., CPACFO & DirectorN/AN/A1951
Mr. Paulo MartinsCEO & Country Director of its operations in PortugalN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


EXMceuticals Inc. engages in the production of cannabinoid formulations. The company primarily focuses around the matching of natural bioactive ingredients extracted from the cannabis plant with the needs of the nutraceutical, cosmeceutical, therapeutic, and pharmaceutical industries. It focuses on the production of CBD, a non-psychoactive cannabinoid that has been proven effective against acne, anxiety, depression, epilepsy, and degenerative diseases, such as Parkinson's; and THC, a psychoactive cannabinoid ingredient that has been proven effective in the fields of pain management, appetite control, anxiety, and managing side effects of chemotherapy. The company was incorporated in 2008 and is headquartered in Quebec, Canada.

Corporate Governance

EXMceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.